OnKure Therapeutics, Inc.
OKUR
$4.07
$0.174.36%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 22.58% | -27.20% | -8.85% | -67.00% | -84.47% |
| Total Depreciation and Amortization | -2.88% | 31.61% | 43.24% | 40.40% | 66.40% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.67% | 3,748.05% | 60.40% | 2,465.42% | 2,553.92% |
| Change in Net Operating Assets | 86.04% | -380.78% | -117.60% | 23.24% | -500.41% |
| Cash from Operations | 50.71% | -22.29% | -105.07% | -31.76% | -232.68% |
| Capital Expenditure | 40.00% | 66.67% | -30.00% | -100.00% | 54.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -100.06% | 66.67% | -30.00% | -100.00% | 48,312.12% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.59% | -- | -- | -- | 654,144.44% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -- | 100.00% | -- | 5,136,300.00% |
| Cash from Financing | -99.78% | -100.00% | -100.00% | -870.00% | 1,102,360.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -110.97% | -22.19% | -2,060.49% | -32.67% | 1,559.63% |